Evidence map›Paper›PMID 39277833›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2025

Impact of the spleen size on short-term prognosis in patients with cardiogenic shock receiving Impella-incorporated temporary mechanical circulatory support.

Makiko Nakamura, Teruhiko Imamura, Hayato Fujioka, Masaki Nakagaito, Hiroshi Ueno, Koichiro Kinugawa

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Makiko NakamuraSecond Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-Shi, Toyama, 930-0194, Japan.
Teruhiko ImamuraSecond Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-Shi, Toyama, 930-0194, Japan. teimamu@med.u-toyama.ac.jp.ORCID http://orcid.org/0000-0002-7294-7637
Hayato FujiokaSecond Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-Shi, Toyama, 930-0194, Japan.
Masaki NakagaitoSecond Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-Shi, Toyama, 930-0194, Japan.
Hiroshi UenoSecond Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-Shi, Toyama, 930-0194, Japan.
Koichiro KinugawaSecond Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-Shi, Toyama, 930-0194, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spleen size may be associated with mortality and morbidity in patients with heart failure, whereas its clinical implication in patients with cardiogenic shock receiving Impella-incorporated temporary mechanical circulatory support (MCS) remains unknown. Patients who received Impella-incorporated temporary MCS in our institute between March 2018 and August 2023 were eligible. The splenic volume index (SVI) was retrospectively calculated in all participants by measuring spleen size on the computed tomography obtained at the time of Impella placement. The impact of baseline SVI/central venous pressure (CVP) ratio on the 30-day mortality after Impella placement was evaluated. A total of 74 patients (70 years old, 62% men) were included. Median baseline SVI was 71.6 (50.3, 92.1) mL/m

Indexed as

Heart-Assist DevicesShock, CardiogenicSpleenAgedCentral Venous PressureFemaleHumansMaleMiddle AgedOrgan SizePrognosisRetrospective StudiesTomography, X-Ray ComputedCardiogenic shockHeart failureLVADPAPi

Identifiers

PMID39277833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.